The Use of Precision Epigenetic Methods for the Diagnosis and Care of Stable Coronary Heart Disease Reduces Healthcare Costs.
David FrisvoldMeeshanthini DoganTimur DoganKhullani AbdullahiTyler KoepRobert A PhilibertPublished in: Advances in therapy (2024)
These analyses support the use of precision epigenetic methods as part of the initial diagnosis and care of stable CHD and can meaningfully reduce cost. Real-world pilots to test the reliability of these analyses are indicated.